Cart
sales@molnova.com
Fulvic Acid
CAS No. 479-66-3
Fulvic Acid( —— )
Catalog No. M35008 CAS No. 479-66-3
Fulvic Acid is a natural product of humus produced by microorganisms in soil, sediment or aquatic environments.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 163 | In Stock |
|
| 5MG | 125 | In Stock |
|
| 10MG | 183 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 445 | In Stock |
|
| 100MG | 638 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1376 | In Stock |
|
| 1G | 1851 | In Stock |
|
Biological Information
-
Product NameFulvic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionFulvic Acid is a natural product of humus produced by microorganisms in soil, sediment or aquatic environments.
-
DescriptionFulvic Acid is a natural product, which comes from humic substances produced by microorganisms in soil. Fulvic Acid can modulate the immune system, influence the oxidative state of cells, and improve gastrointestinal function. Fulvic Acid has the potential for researching chronic inflammatory diseases, including diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
RecptorAntioxidant | PDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number479-66-3
-
Formula Weight308.24
-
Molecular FormulaC14H12O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(O)Cc2oc3cc(O)c(O)c(C(O)=O)c3c(=O)c2CO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Winkler J, et al. Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes. J Diabetes Res. 2018;2018:5391014. Published 2018 Sep 10. ?
molnova catalog
related products
-
Valepotriate
Valepotriate fraction can have sedative effects and affect behavioral parameters related to recognition memory.
-
Nrf2 activator-3
Nrf2 activator-3 is a potent Nrf2 activator with potential anti-inflammatory, antioxidant, and anti-tumor activities, suitable for studying neurological and immune-related diseases.
-
BMY-21502
BMY-21502 is a potential cognitive enhancer that shows anti-hypoxia effects in the KCN-hypoxia model, delays the decay of hippocampal synaptic enhancement in vitro, and can be used to study Alzheimer's disease.
